Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.9K Sell
21,934
-332
-1% -$1.04K ﹤0.01% 1757
2026
Q1
$65K Buy
22,266
+2,489
+13% +$7.11K ﹤0.01% 1611
2025
Q4
$48.8K Buy
19,777
+1,662
+9% +$3.96K ﹤0.01% 1525
2025
Q3
$40.4K Buy
18,115
+1,817
+11% +$4.16K ﹤0.01% 1499
2025
Q2
$39.3K Buy
16,298
+196
+1% +$477 ﹤0.01% 1470
2025
Q1
$37.5K Buy
+16,102
New +$32.2K ﹤0.01% 1405

Other funds holding ABEV

Xponance's ABEV Position: Q2 2026 in Review

Xponance reduced its Ambev (ABEV) stake by 1.5% in Q2 2026, selling an estimated $1.04K and leaving 21,934 shares worth $68.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Xponance first reported a position in ABEV in Q1 2025 and has held it in 6 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Xponance held 21,934 shares of Ambev worth $68.9K as of Q2 2026.
  • Xponance sold 332 Ambev shares in Q2 2026, an estimated $1.04K.
  • Ambev made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1757 holding.
  • Xponance first reported a position in Ambev in Q1 2025 and has held it in 6 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.